MedTrace Logo

Influenza Immunization of Children in India

NCT01680679 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 18163

Last updated 2017-03-24

No results posted yet for this study

Summary

Influenza viruses are significant causes of human illness and death in developed and developing countries. This study will measure the ability of influenza vaccine given to children in India to protect both the children and unimmunized persons around them from influenza. It will also determine whether the best time to immunize in a country like India that has both summer and winter outbreaks of influenza is in the fall, as is done now, or whether immunization should be in the spring to protect against influenza infections in the summer.

Conditions

Interventions

BIOLOGICAL

Inactivated Trivalent Influenza Vaccine (TIV)

BIOLOGICAL

Inactivated poliovirus vaccine (IPV), trivalent

Sponsors & Collaborators

  • All India Institute of Medical Sciences

    collaborator OTHER

  • International Clinical Epidemiology Network (INCLEN) TRUST

    collaborator NETWORK

  • University of Alabama at Birmingham

    collaborator OTHER

  • Centers for Disease Control and Prevention

    collaborator FED

  • University of Colorado, Denver

    lead OTHER

Principal Investigators

  • Wayne Sullender, MD · University of Colorado, Denver

  • Shobha Broor, MD · All India Institute of Medical Sciences

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
6 Months
Max Age
10 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-05-31
Primary Completion
2014-05-31
Completion
2014-05-31

Countries

  • India

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01680679 on ClinicalTrials.gov